Cytology automation: An overview

Despite the unquestioned success of the Papanicolaou (Pap) smear in diminishing cervical cancer deaths in screened populations, the limitations of manual screening still exist, prompting the development of viable automated systems to improve the sensitivity of cervical screening. Rapid technological progress in new thin layer preparation machines and automated screening systems over the last decade has resulted in the availability of an a few FDA approved automated primary screening device devices that are assisting the cytologist in the laboratory.